April 29th, 2020
•Presented here is a protocol to evaluate the inhibition efficacy of chemical compounds against in vitro intracellular growth of Toxoplasma gondii using a luciferase-based growth assay. The technique is used to confirm inhibition specificity by genetic deletion of the corresponding target gene. The inhibition of LHVS against TgCPL protease is evaluated as an example.
Related Videos
Obtaining Highly Purified Toxoplasma gondii Oocysts by a Discontinuous Cesium Chloride Gradient Video (Video) | JoVE
Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions Video (Video) | JoVE
Transnuclear Mice with Pre-defined T Cell Receptor Specificities Against Toxoplasma gondii Obtained Via SCNT Video (Video) | JoVE
A Genetic Screen to Isolate Toxoplasma gondii Host-cell Egress Mutants Video (Video) | JoVE
Growth of Mycobacterium tuberculosis Biofilms Video (Video) | JoVE
A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line Video (Video) | JoVE
Staphylococcus aureus Growth using Human Hemoglobin as an Iron Source Video (Video) | JoVE
Genetic Manipulation in Δku80 Strains for Functional Genomic Analysis of Toxoplasma gondii Video (Video) | JoVE
Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity Video (Video) | JoVE
Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses Video (Video) | JoVE
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved